Robin B. Jarrett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robin B. Jarrett has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey R. Vittengl
Truman State University, USA
7 shared publications - Lee Anna Clark
Department of Psychology, University of Notre Dame
7 shared publications - Michael E. Thase
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
4 shared publications - Jason Zafereo
Department of Physical Therapy, University of Texas Southwestern Medical Center, Dallas, TX, USA
2 shared publications - Karen J. Meltzer
Department of Psychology, Division of Psychiatry, The University of Texas Southwestern Medical Center
2 shared publications Michael E. Thase
Department of Psychiatry
2 shared publications
Latest Publications
- Open Access
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Agreement between Fitbit Versa 4 and a reference standard on time-domain nocturnal heart rate variability: A pilot study
Background: Reduced heart rate variability (HRV) has been associated with impaired autonomic nervous system (ANS) adaptation, suggesting that HRV could serve as a biomarker for identifying ANS imbalances that may adversely affect an individual's overall health. Many wearable devices used outside medical settings provide measures of HRV, but clinimetric data on their reliability and agreement remain limited. The primary aim of this study was to assess the ability of the Fitbit Versa 4, a consumer-based wearable, to measure nocturnal HRV compared to a reference standard HRV measure obtained from an ambulatory ECG device, the Firstbeat Bodyguard 3. Methods: Eight participants simultaneously wore the Fitbit Versa 4 and Firstbeat Bodyguard 3 beginning at least one hour before sleep, throughout their sleep period, and for at least one hour after waking, over a minimum of three nights. HRV was quantified using the root mean square of successive differences (RMSSD). A t-test assessed differences in median HRV between devices, while a Linear Mixed Model and Bland-Altman analysis evaluated relative difference and agreement, respectively. Results: The median RMSSD from Fitbit (21.660 ms [15.927, 22.821]) was not significantly different ( p = 0.3858) from the median RMSSD from Firstbeat (20.558 ms [13.648, 21.828]. Linear Mixed Model results indicated that, on average, Firstbeat measurements were approximately 92.3% of those obtained from Fitbit. Conclusions: Strong correlation and acceptable agreement between Fitbit Versa 4 HRV measurements and reference standard HRV measurements derived from ECG provide preliminary support for using Fitbit Versa 4 to measure nocturnal HRV outside laboratory settings.
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessAgreement between Fitbit Versa 4 and a reference standard on time-domain nocturnal heart rate variability: A pilot study
Background: Reduced heart rate variability (HRV) has been associated with impaired autonomic nervous system (ANS) adaptation, suggesting that HRV could serve as a biomarker for identifying ANS imbalances that may adversely affect an individual's overall health. Many wearable devices used outside medical settings provide measures of HRV, but clinimetric data on their reliability and agreement remain limited. The primary aim of this study was to assess the ability of the Fitbit Versa 4, a consumer-based wearable, to measure nocturnal HRV compared to a reference standard HRV measure obtained from an ambulatory ECG device, the Firstbeat Bodyguard 3. Methods: Eight participants simultaneously wore the Fitbit Versa 4 and Firstbeat Bodyguard 3 beginning at least one hour before sleep, throughout their sleep period, and for at least one hour after waking, over a minimum of three nights. HRV was quantified using the root mean square of successive differences (RMSSD). A t-test assessed differences in median HRV between devices, while a Linear Mixed Model and Bland-Altman analysis evaluated relative difference and agreement, respectively. Results: The median RMSSD from Fitbit (21.660 ms [15.927, 22.821]) was not significantly different ( p = 0.3858) from the median RMSSD from Firstbeat (20.558 ms [13.648, 21.828]. Linear Mixed Model results indicated that, on average, Firstbeat measurements were approximately 92.3% of those obtained from Fitbit. Conclusions: Strong correlation and acceptable agreement between Fitbit Versa 4 HRV measurements and reference standard HRV measurements derived from ECG provide preliminary support for using Fitbit Versa 4 to measure nocturnal HRV outside laboratory settings.
- Open Access
- 17 February 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e50
Psychological interventions for preventing relapse in individuals with partial remission of depression: a systematic review and individual participant data meta-analysis
Partial remission after major depressive disorder (MDD) is common and a robust predictor of relapse. However, it remains unclear to which extent preventive psychological interventions reduce depressive symptomatology and relapse risk after partial remission. We aimed to identify variables predicting relapse and to determine whether, and for whom, psychological interventions are effective in preventing relapse, reducing (residual) depressive symptoms, and increasing quality of life among individuals in partial remission. This preregistered (CRD42023463468) systematic review and individual participant data meta-analysis (IPD-MA) pooled data from 16 randomized controlled trials (n = 705 partial remitters) comparing psychological interventions to control conditions, using 1- and 2-stage IPD-MA. Among partial remitters, baseline clinician-rated depressive symptoms (p = .005) and prior episodes (p = .012) predicted relapse. Psychological interventions were associated with reduced relapse risk over 12 months (hazard ratio [HR] = 0.60, 95% confidence interval [CI] 0.43–0.84), and significantly lowered posttreatment depressive symptoms (Hedges’ g = 0.29, 95% CI 0.04–0.54), with sustained effects at 60 weeks (Hedges’ g = 0.33, 95% CI 0.06–0.59), compared to nonpsychological interventions. However, interventions did not significantly improve quality of life at 60 weeks (Hedges’ g = 0.26, 95% CI -0.06 to 0.58). No moderators of relapse prevention efficacy were found. Men, older individuals, and those with higher baseline symptom severity experienced greater reductions in symptomatology at 60 weeks. Psychological interventions for individuals with partially remitted depression reduce relapse risk and residual symptomatology, with efficacy generalizing across patient characteristics and treatment types. This suggests that psychological interventions are a recommended treatment option for this patient population.
- 17 February 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e50
Open AccessPsychological interventions for preventing relapse in individuals with partial remission of depression: a systematic review and individual participant data meta-analysis
Partial remission after major depressive disorder (MDD) is common and a robust predictor of relapse. However, it remains unclear to which extent preventive psychological interventions reduce depressive symptomatology and relapse risk after partial remission. We aimed to identify variables predicting relapse and to determine whether, and for whom, psychological interventions are effective in preventing relapse, reducing (residual) depressive symptoms, and increasing quality of life among individuals in partial remission. This preregistered (CRD42023463468) systematic review and individual participant data meta-analysis (IPD-MA) pooled data from 16 randomized controlled trials (n = 705 partial remitters) comparing psychological interventions to control conditions, using 1- and 2-stage IPD-MA. Among partial remitters, baseline clinician-rated depressive symptoms (p = .005) and prior episodes (p = .012) predicted relapse. Psychological interventions were associated with reduced relapse risk over 12 months (hazard ratio [HR] = 0.60, 95% confidence interval [CI] 0.43–0.84), and significantly lowered posttreatment depressive symptoms (Hedges’ g = 0.29, 95% CI 0.04–0.54), with sustained effects at 60 weeks (Hedges’ g = 0.33, 95% CI 0.06–0.59), compared to nonpsychological interventions. However, interventions did not significantly improve quality of life at 60 weeks (Hedges’ g = 0.26, 95% CI -0.06 to 0.58). No moderators of relapse prevention efficacy were found. Men, older individuals, and those with higher baseline symptom severity experienced greater reductions in symptomatology at 60 weeks. Psychological interventions for individuals with partially remitted depression reduce relapse risk and residual symptomatology, with efficacy generalizing across patient characteristics and treatment types. This suggests that psychological interventions are a recommended treatment option for this patient population.
- 14 March 2023
- Published by S. Karger AG in Psychotherapy and Psychosomatics
- Vol. 92 (2) , 133-138
Evaluating a Comprehensive Model of Euthymia
Introduction: In research and treatment of mood disorders, “euthymia” traditionally denotes the absence of clinically significant mood disturbance. A newer, expanded definition of euthymia also includes positive affect and psychological well-being. Objective: We aimed to test this comprehensive model of euthymia and estimate the coherence and predictive power of each factor in the model. Methods: Community-dwelling adults (N = 601), including both mental health outpatients and non-patients at high risk for personality pathology, completed a battery of interviews and questionnaires at time 1. Most (n = 497) were reassessed on average 8 months later (time 2). We modeled euthymia using standard mood, personality, and psychosocial functioning assessments rather than measures designed specifically for euthymia. Results: The hypothesized model of euthymia was supported by confirmatory factor analysis: specific measures loaded on three lower order factors (mood disturbance, positive affect, and psychological well-being) that reflected general euthymia at time 1. Each factor (general euthymia plus lower order factors) demonstrated moderately strong concurrent (time 1) and predictive (time 1–2) correlations with outcomes, including employment status, income, mental health treatment consumption, and disability. Compared to positive affect and psychological well-being, mood disturbance had stronger incremental (i.e., nonoverlapping) relations with these outcomes. Conclusions: Support for a comprehensive model of euthymia reinforces efforts to improve assessment and treatment of mood and other disorders. Beyond dampening of psychological distress, euthymia-informed treatment goals encompass full recovery, including enjoyment and meaning in life.
- 14 March 2023
- Published by S. Karger AG in Psychotherapy and Psychosomatics
- Vol. 92 (2) , 133-138
Evaluating a Comprehensive Model of Euthymia
Introduction: In research and treatment of mood disorders, “euthymia” traditionally denotes the absence of clinically significant mood disturbance. A newer, expanded definition of euthymia also includes positive affect and psychological well-being. Objective: We aimed to test this comprehensive model of euthymia and estimate the coherence and predictive power of each factor in the model. Methods: Community-dwelling adults (N = 601), including both mental health outpatients and non-patients at high risk for personality pathology, completed a battery of interviews and questionnaires at time 1. Most (n = 497) were reassessed on average 8 months later (time 2). We modeled euthymia using standard mood, personality, and psychosocial functioning assessments rather than measures designed specifically for euthymia. Results: The hypothesized model of euthymia was supported by confirmatory factor analysis: specific measures loaded on three lower order factors (mood disturbance, positive affect, and psychological well-being) that reflected general euthymia at time 1. Each factor (general euthymia plus lower order factors) demonstrated moderately strong concurrent (time 1) and predictive (time 1–2) correlations with outcomes, including employment status, income, mental health treatment consumption, and disability. Compared to positive affect and psychological well-being, mood disturbance had stronger incremental (i.e., nonoverlapping) relations with these outcomes. Conclusions: Support for a comprehensive model of euthymia reinforces efforts to improve assessment and treatment of mood and other disorders. Beyond dampening of psychological distress, euthymia-informed treatment goals encompass full recovery, including enjoyment and meaning in life.
- 1 February 2023
- Published by American Psychological Association (APA) in Rehabilitation Psychology
- Vol. 68 (1) , 65-76
Predictors of attrition in an interdisciplinary pain management program.
Purpose/Objective: This study sought to investigate the extent to which demographic and clinical characteristics predict which patients drop out of an interdisciplinary pain management program (IPP). Research Method/Design: Participants (N = 178 outpatients, 18-75 years of age) received treatment for various chronic pain conditions in an IPP (including biopsychosocial assessment, cognitive-behavioral. and physical therapies). Separate logistic regression analyses identified the demographic and clinical variables most predictive of attrition across five domains: (a) demographics. (b) number of medical and non/psychiatric diagnoses, (c) opioid use (yes versus no)/risk of misuse. (d) pain-related cognition and behavior. and (e) physical, social. and mental well-being. Significant predictors from the five domains were integrated in a final multivariable logistic regression model. Results: Among patients exposed to a 4-week IPP, 34% dropped out. In the final model, significant predictors of higher odds of attrition included younger age or being unemployed. Also, patients on opioids at preintervention had higher odds of completing the IPP than patients not on opioids at preintervention. Follow-up analyses revealed 24 of 37 completers (65%) on opioids at preintervention reduced or eliminated use over the course of the IPP. Conclusions/Implications: Because findings are limited by sample and design characteristics, they require replication yet offer novel hypotheses for identifying patients at risk of attrition. Specifically, patients with preintervention opioid use (contrasted with opioid dependence) may particularly benefit from an IPP. Patients at highest risk for early dropout can be targeted for specific engagement interventions to promote completion and effectiveness of IPP.
- 1 February 2023
- Published by American Psychological Association (APA) in Rehabilitation Psychology
- Vol. 68 (1) , 65-76
Predictors of attrition in an interdisciplinary pain management program.
Purpose/Objective: This study sought to investigate the extent to which demographic and clinical characteristics predict which patients drop out of an interdisciplinary pain management program (IPP). Research Method/Design: Participants (N = 178 outpatients, 18-75 years of age) received treatment for various chronic pain conditions in an IPP (including biopsychosocial assessment, cognitive-behavioral. and physical therapies). Separate logistic regression analyses identified the demographic and clinical variables most predictive of attrition across five domains: (a) demographics. (b) number of medical and non/psychiatric diagnoses, (c) opioid use (yes versus no)/risk of misuse. (d) pain-related cognition and behavior. and (e) physical, social. and mental well-being. Significant predictors from the five domains were integrated in a final multivariable logistic regression model. Results: Among patients exposed to a 4-week IPP, 34% dropped out. In the final model, significant predictors of higher odds of attrition included younger age or being unemployed. Also, patients on opioids at preintervention had higher odds of completing the IPP than patients not on opioids at preintervention. Follow-up analyses revealed 24 of 37 completers (65%) on opioids at preintervention reduced or eliminated use over the course of the IPP. Conclusions/Implications: Because findings are limited by sample and design characteristics, they require replication yet offer novel hypotheses for identifying patients at risk of attrition. Specifically, patients with preintervention opioid use (contrasted with opioid dependence) may particularly benefit from an IPP. Patients at highest risk for early dropout can be targeted for specific engagement interventions to promote completion and effectiveness of IPP.
- 29 March 2022
- Published by Taylor & Francis in Pain Management
- Vol. 12 (5) , 623-633
Using Quantitative Sensory Testing to Predict Attrition in an Interdisciplinary Pain Management Program: A Pilot Study
Aim: To determine the extent to which quantitative sensory testing (QST) predicted attrition in an interdisciplinary pain program (IPP). Patients & methods: Participants (n = 53) enrolled in an IPP... Plain language summary The purpose of this research study was to determine the extent to which quantitative sensory testing (QST) predicted which patients enrolled in an interdisciplinary pain prog...
- 29 March 2022
- Published by Taylor & Francis in Pain Management
- Vol. 12 (5) , 623-633
Using Quantitative Sensory Testing to Predict Attrition in an Interdisciplinary Pain Management Program: A Pilot Study
Aim: To determine the extent to which quantitative sensory testing (QST) predicted attrition in an interdisciplinary pain program (IPP). Patients & methods: Participants (n = 53) enrolled in an IPP... Plain language summary The purpose of this research study was to determine the extent to which quantitative sensory testing (QST) predicted which patients enrolled in an interdisciplinary pain prog...
- 27 August 2020
- Published by American Psychological Association (APA) in Psychological Assessment
- Vol. 32 (11) , 1028-1036
Psychometric properties of the Marital Adjustment Scale during cognitive therapy for depression: New research opportunities.
Poor dyadic adjustment in marital or similar relationships is common among patients seeking individual cognitive therapy (CT) for major depressive disorder (MDD). Here we examined the psychometric properties of the marital adjustment subscale (MAS) of the Social Adjustment Scale—Self-report (SAS-SR; Weissman & Bothwell, 1976). Among married or cohabiting patients receiving individual CT for recurrent MDD (N = 306) in the context of two randomized controlled trials, the MAS demonstrated moderate internal consistency and test-retest reliability, strong convergence with the Dyadic Adjustment Scale (DYS; Spanier, 1976), and moderate relations with interpersonal problems and depressive symptoms. Controlling baseline depressive symptom severity, greater pre-CT relationship discord on the MAS predicted less reduction in depressive symptom severity and lower odds of depression remission during CT. These results support the reliability, validity, and potential utility of the MAS. Using the MAS may help investigators “mine” existing datasets including the SAS-SR to further understanding of dyadic functioning and its potential impact on depression treatment and other health outcomes.
- 27 August 2020
- Published by American Psychological Association (APA) in Psychological Assessment
- Vol. 32 (11) , 1028-1036
Psychometric properties of the Marital Adjustment Scale during cognitive therapy for depression: New research opportunities.
Poor dyadic adjustment in marital or similar relationships is common among patients seeking individual cognitive therapy (CT) for major depressive disorder (MDD). Here we examined the psychometric properties of the marital adjustment subscale (MAS) of the Social Adjustment Scale—Self-report (SAS-SR; Weissman & Bothwell, 1976). Among married or cohabiting patients receiving individual CT for recurrent MDD (N = 306) in the context of two randomized controlled trials, the MAS demonstrated moderate internal consistency and test-retest reliability, strong convergence with the Dyadic Adjustment Scale (DYS; Spanier, 1976), and moderate relations with interpersonal problems and depressive symptoms. Controlling baseline depressive symptom severity, greater pre-CT relationship discord on the MAS predicted less reduction in depressive symptom severity and lower odds of depression remission during CT. These results support the reliability, validity, and potential utility of the MAS. Using the MAS may help investigators “mine” existing datasets including the SAS-SR to further understanding of dyadic functioning and its potential impact on depression treatment and other health outcomes.
- Open Access
- 1 July 2019
- Published by Elsevier in Behavior Therapy
- Vol. 50 (4) , 765-777
Could Treatment Matching Patients’ Beliefs About Depression Improve Outcomes?
- 1 July 2019
- Published by Elsevier in Behavior Therapy
- Vol. 50 (4) , 765-777
Open AccessCould Treatment Matching Patients’ Beliefs About Depression Improve Outcomes?
- Open Access
- 1 February 2019
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 113, 48-56
Partner criticism during acute-phase cognitive therapy for recurrent major depressive disorder
- 1 February 2019
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 113, 48-56
Open AccessPartner criticism during acute-phase cognitive therapy for recurrent major depressive disorder
- Open Access
- 22 June 2015
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 45 (15) , 3191-3204
Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder
Background.: The cognitive model of depression suggests that cognitive therapy (CT) improves major depressive disorder (MDD) in part by changing depressive cognitive content (e.g. dysfunctional attitudes, hopelessness). The current analyses clarified: (1) the durability of improvements in cognitive content made by acute-phase CT responders; (2) whether continuation-phase CT (C-CT) or fluoxetine (FLX) further improves cognitive content; and (3) the extent to which cognitive content mediates continuation treatments’ effects on depressive symptoms and major depressive relapse/recurrence.Method.: Out-patients with recurrent MDD who responded to acute-phase CT (n = 241) were randomized to 8 months of C-CT, FLX or pill placebo (PBO) and followed for an 24 additional months. Cognitive content was assessed approximately every 4 months using five standard patient-report measures.Results.: Large improvements in cognitive content made during acute-phase CT were maintained for 32 months, with 78–90% of patients scoring in normal ranges, on average. Cognitive content varied little between C-CT, FLX and PBO arms, overall. Small, transient improvements in cognitive content in C-CT or FLX compared with PBO patients did not clearly mediate the treatments’ effects on depressive symptoms or on major depressive relapse/recurrence.Conclusions.: Outpatients with recurrent MDD who respond to acute-phase CT show durable improvements in cognitive content. C-CT or FLX may not continue to improve patient-reported cognitive content substantively, and thus may treat recurrent MDD by other paths.
- 22 June 2015
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 45 (15) , 3191-3204
Open AccessImproved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder
Background.: The cognitive model of depression suggests that cognitive therapy (CT) improves major depressive disorder (MDD) in part by changing depressive cognitive content (e.g. dysfunctional attitudes, hopelessness). The current analyses clarified: (1) the durability of improvements in cognitive content made by acute-phase CT responders; (2) whether continuation-phase CT (C-CT) or fluoxetine (FLX) further improves cognitive content; and (3) the extent to which cognitive content mediates continuation treatments’ effects on depressive symptoms and major depressive relapse/recurrence.Method.: Out-patients with recurrent MDD who responded to acute-phase CT (n = 241) were randomized to 8 months of C-CT, FLX or pill placebo (PBO) and followed for an 24 additional months. Cognitive content was assessed approximately every 4 months using five standard patient-report measures.Results.: Large improvements in cognitive content made during acute-phase CT were maintained for 32 months, with 78–90% of patients scoring in normal ranges, on average. Cognitive content varied little between C-CT, FLX and PBO arms, overall. Small, transient improvements in cognitive content in C-CT or FLX compared with PBO patients did not clearly mediate the treatments’ effects on depressive symptoms or on major depressive relapse/recurrence.Conclusions.: Outpatients with recurrent MDD who respond to acute-phase CT show durable improvements in cognitive content. C-CT or FLX may not continue to improve patient-reported cognitive content substantively, and thus may treat recurrent MDD by other paths.
- Open Access
- 1 April 2014
- Published by Guilford Publications in Journal of Personality Disorders
- Vol. 28 (2) , 225-246
Replication and Extension: Separate Personality Traits From States to Predict Depression
Changes in personality trait levels often parallel episodes of major depressive disorder (MDD), whereas trait factor structures and substantial retest correlations are preserved. The authors explicated this dual state/trait nature of personality assessments among adults with recurrent MDD (N = 351) receiving cognitive therapy (CT) by testing stability and change with the Schedule for Nonadaptive and Adaptive Personality, 2nd Edition (SNAP-2; Clark, Simms, Wu, & Casillas, in press), separating state and trait variance, and predicting depressive symptoms and clinical outcomes. Many SNAP scale scores changed in CT (e.g., positive temperament increased, negative temperament decreased), and decreases in depressive symptoms accounted for most scales' score changes. Nonetheless, SNAP scales' state and trait components predicted depressive symptoms early and late in CT as well as clinical outcomes, and state components predicted changes in symptoms and clinical outcomes. These results support the validity of the ...
- 1 April 2014
- Published by Guilford Publications in Journal of Personality Disorders
- Vol. 28 (2) , 225-246
Open AccessReplication and Extension: Separate Personality Traits From States to Predict Depression
Changes in personality trait levels often parallel episodes of major depressive disorder (MDD), whereas trait factor structures and substantial retest correlations are preserved. The authors explicated this dual state/trait nature of personality assessments among adults with recurrent MDD (N = 351) receiving cognitive therapy (CT) by testing stability and change with the Schedule for Nonadaptive and Adaptive Personality, 2nd Edition (SNAP-2; Clark, Simms, Wu, & Casillas, in press), separating state and trait variance, and predicting depressive symptoms and clinical outcomes. Many SNAP scale scores changed in CT (e.g., positive temperament increased, negative temperament decreased), and decreases in depressive symptoms accounted for most scales' score changes. Nonetheless, SNAP scales' state and trait components predicted depressive symptoms early and late in CT as well as clinical outcomes, and state components predicted changes in symptoms and clinical outcomes. These results support the validity of the ...